Budget Amount *help |
¥3,302,000 (Direct Cost: ¥2,540,000、Indirect Cost: ¥762,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥1,742,000 (Direct Cost: ¥1,340,000、Indirect Cost: ¥402,000)
|
Research Abstract |
Tumor suppressor CYLD has been recently shown to play important roles in the pathogenesis of various intractable diseases. In the present study, we focused on the CYLD-related diseases (1. lung fibrosis, 2. chronic obstructive pulmonary disease, 3. familial amyloidotic polyneuropathy) and revealed that CYLD acted as a deubiquitinase and involved in various diseases by suppressing intracellular signaling, such as TGFβ signal and NF-κB signal to regulate the disease-related gene expression.
|